The Role of HDAC3 in Pulmonary Diseases
Lung · 2025
DOI: 10.1007/s00408-025-00798-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lung, 2025. Verfasst von Leyu Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta West Road No.277, Xi'an, 710061, Shaanxi, China. Hauptthemen laut MEDLINE: Histone Deacetylases, Lung Neoplasms, Lung Diseases, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 85 Literaturangaben.
Abstract (Originalsprache)
Histone deacetylases (HDACs), a class of enzymes involved in epigenetic modifications, play a pivotal role in modulating chromatin structure and gene expression. Among these, histone deacetylase 3 (HDAC3) has emerged as a key regulator in diverse cellular pathophysiological processes. The remarkable therapeutic potential of HDAC inhibitors in lung cancer has intensified research into the role of HDAC3 in pulmonary diseases. Through deacetylating histones and non-histone proteins, HDAC3 has been increasingly recognized for its critical involvement in regulating inflammatory responses, fibrotic processes, and oncogenic signaling pathways, positioning it as a compelling therapeutic target. This review systematically examines the structural and functional features of HDAC3 and discusses its multifaceted contributions to pulmonary pathologies, including lung injury, pulmonary fibrosis, and lung cancer. Additionally, we critically evaluate advances in HDAC inhibitor-based therapies for lung cancer, with emphasis on the development of HDAC3-targeted therapies. As a promising therapeutic target for pulmonary diseases, HDAC3 needs to be further investigated to elucidate its regulatory mechanisms and facilitate the development of selective inhibitors for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta West Road No.277, Xi'an, 710061, Shaanxi, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Yan Ta West Road No.277, Xi'an, 710061, Shaanxi, China. wuqifei-1@163.com.
- Key Laboratory of Surgical Critical Care and Life Support (Xi'an Jiaotong University), Ministry of Education, Xi'an, China. wuqifei-1@163.com.
Zitieren
APA
Hong, L., Ni, M., Xue, F., Jiang, T., Wu, X., Li, C., Liang, S., Chen, T., Luo, C., & Wu, Q. (2025). The Role of HDAC3 in Pulmonary Diseases. Lung. https://doi.org/10.1007/s00408-025-00798-3
Vancouver
Hong L, Ni M, Xue F, Jiang T, Wu X, Li C, et al. The Role of HDAC3 in Pulmonary Diseases. Lung. 2025. doi:10.1007/s00408-025-00798-3
BibTeX
@article{Hong2025,
author = {Hong, Leyu and Ni, Ming and Xue, Fei and Jiang, Tao and Wu, Xuanpeng and Li, Chenxi and Liang, Shuhao and Chen, Tianhao and Luo, Chao and Wu, Qifei},
title = {The Role of HDAC3 in Pulmonary Diseases},
journal = {Lung},
year = {2025},
doi = {10.1007/s00408-025-00798-3}
}
EUVIMED